Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
Status:
Unknown status
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish an efficient and economic treatment scheme by
evaluation of the safety and efficacy of subcutaneous injection of low-dose rhGM-CSF, or of
similar injection after whole lung lavage , in patients with PAP.